Navigation Links
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Date:5/11/2009

eutics.com>bd@logicaltherapeutics.com" target="_new">bd@logicaltherapeutics.com


'/>"/>
SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...DELFT,TheNetherlandsandJOHANNESBURG,November25/PRN...ndPyxisDiscoveryannouncedtoday,thattheyhavesigneda...s,services. , Pyxis,sworldclasscomputationalc...hiThemba,sservicedivisiontoprovidemedicinaland,syn...yxis,internationalclientnetwork.iThembaPharmaceut...
(Date:11/25/2009)...MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCen...afromtheCompany,sPROTECT-1(theProspectiveRandomize...icet-EN(TM)(CCX282-B)inpatientswithmoderate-to-sev...favorablesafetyandtolerabilityprofile.Thestudydemo...diseaseseverityasdefinedasa70-pointdecreaseintheCr...
(Date:11/24/2009)...PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoub...llowinganautoaccident,wasactuallyfullyconsciousand...mericasegment.TheDynaVoxEyeMaxwasfeaturedinthesegm...herconditionscanunlockcommunication. ,, WHEN:Go...ineat www.dynavoxtech.com ,, WHO:RomHoub...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Watson Files FDA Application for Generic Mucinex 28R 29 D 48412 1Watson Files FDA Application for Generic Mucinex 28R 29 D 48412 2Watson Files FDA Application for Generic Mucinex 28R 29 D 48412 3Swim Yourself Slim This Summer With AXA PPP Healthcares Nutrition and Fitness Expert Guide 48410 1Swim Yourself Slim This Summer With AXA PPP Healthcares Nutrition and Fitness Expert Guide 48410 2Swim Yourself Slim This Summer With AXA PPP Healthcares Nutrition and Fitness Expert Guide 48410 3Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 1Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 2
...N, 12 July 2007 - Cancer drug developer Antisoma p...ata from its phase,II trial of ASA404 in recurrent...mpares patients receiving ASA404 plus chemotherapy... (n=38). The main,findings are as follows: , * The...ession in,the ASA404 arm compared with the control...
...LE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wed....m. Eastern/10:30 p.m.,Central European Time membe...eam will host a conference call to discuss today,s...II/III RAPID trial,comparing CHOP-R to CPOP-R, in ... standard CHOP-R, in first-line treatment of patie...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
(Date:11/25/2009)... Evaluation and treatment clinics to re...odstock (Vocus) November 25, 2009 -- Centegra Heal...es and H1N1 vaccine shots at four Centegra Primary...ment of vaccine has arrived. The clinics are at CP...Henry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...24 United American Healthcare,Corporation (Nasdaq...ncial,results for the second fiscal quarter ended ...ket close. The Company will host a conference call...onal investors and analysts. Individual investors ...
...n. 24 The Advisory Board,Company (Nasdaq: ABCO )...ference call hosted by Frank J. Williams, Chairman...baum, Chief Financial Officer, to discuss the,Comp...mpany plans to release its third quarter financial...
...ccreditation standards for Specialty Pharmacy, Wor...INGTON, Jan. 24 URAC called for public,comment to...The programs,are Specialty Pharmacy, Mail Service ...ng Pharmacy Benefit,Management Accreditation stand...
.... 24 MediKeeper,( http://www.medikeeper.com ), a ...ealth and wellness industry, today announced its a...s Senior VP/Sales to lead expansion of,strategic s...lth and,wellness. Its Personal Health Record (PHR)...
...ill Benefit HIV/AIDS Patients in Broward County an...on-Cutting Ceremony, Refreshments, Free HIV Testi...e Foundation (AHF) will mark the opening of its ne... 10:00 a.m. This,festive community open house will...
...have discovered that mice genetically engineered t...ound deafness and seizures. The finding suggests a...auses of deafness and epilepsy in humans. , More ... the team, led by scientists at the University of ...
Other Medicine News:Health News:The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008 2Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 2Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 3Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 4Health News:Global Sales Veteran Jack McGovern Joins MediKeeper 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 3Health News:Deafness and seizures result when mysterious protein deleted in mice 2Health News:Deafness and seizures result when mysterious protein deleted in mice 3
HemoCue 201 DM System, Glucose
Triage® C. difficile Panel
Bartels® C. Difficile Toxin A Antigen EIA with Controls
... Toxin A C. difficile Rapid Toxin A Test gives you...minutes. When it might be C. difficile, you can't ...nly a few tests a day or sends out its suspected C...C. difficile Rapid Toxin A Test will cut costs and...
Medicine Products: